Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP9X inhibits TGFB. 3 / 3

| 3

➶

reach

"Where indicated, control cells were supplemented with 5 muM SB431542 (Tocris) in the medium to quench autocrine TGFbeta signaling.For FAM knockdown, the sequences of the siRNA were as follows : # 1 : [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

19135894

➶

reach

"Depletion of FAM or Smad4 abolished TGFbeta induced migration."

19135894

➶

reach

"Thus loss of USP9x can increase TGFbeta signaling, potentially contributing to tumorigenesis."

27462448

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP9X inhibits TGFB. 3 / 3

Our Sources:

Databases

Reading